The University of Texas MD Anderson Cancer Center announced Kerin Adelson, M.D., as the institution’s chief quality and value officer. An accomplished clinician and researcher with extensive leadership experience in delivering high-quality and value-based cancer care, Adelson will recently begin her role.
As chief quality and value officer, Adelson will partner with Chief Administrative Quality Officer José Rivera to lead MD Anderson’s medical practice quality improvement efforts and value-based care initiatives in support of the institution’s Strategy. She also will be responsible for guiding initiatives aimed at optimizing the cost and quality of patient care and demonstrating value to prospective insurers, with a goal of implementing innovative reimbursement models that increase access to cancer care services here and across the MD Anderson Cancer Network®.
Adelson also will provide strategic oversight and support for the Institute for Cancer Care Innovation, patient care informatics medical directors, and teams working on clinical effectiveness, tumor registry, and Cancer Network quality improvement. She will collaborate with Rivera to provide leadership for the Quality Assessment and Performance Improvement (QAPI) council and with Chief Patient Safety Officer Carmen Gonzalez, M.D., to provide support for MD Anderson’s Divisional Patient Safety Quality Officers.
“As we continue to advance our mission to end cancer, we are committed to improving the lives of our patients and their families. Central to that is our strategic focus on high-touch, high-value cancer care,” said Peter WT Pisters, M.D., president of MD Anderson. “Dr. Adelson brings tremendous experience and insightful leadership that will help us to advance our efforts in this space and ensure optimal, value-based care for all patients.”